Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
We report a case of tubercular prostatic abscess in a patient who had undergone intravesical bacillus Calmette-Guérin immunotherapy for bladder carcinoma in situ. The abscess required surgical drainage and antituberculous treatment.
Aust
Thomas R
TR
Department of Urology and General Surgery, Whiston Hospital, Merseyside, UK. tomaust@doctors.org.uk
Massey
J Adrian
JA
D000038:Abscess / Q000139:chemically induced* / Q000382:microbiology / Q000601:surgery; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects; D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009163:Mycobacterium bovis / Q000302:isolation & purification; D011468:Prostatectomy; D011472:Prostatitis / Q000139:chemically induced* / Q000382:microbiology / Q000601:surgery; D014389:Tuberculosis, Male Genital / Q000139:chemically induced* / Q000382:microbiology / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine